CD28 CO-STIMULATION AND CANCER IMMUNOTHERAPY WITH CHIMERIC ANTIGEN RECEPTOR-MODIFIED NATURAL KILLER CELLS
Ph.D
Saved in:
Main Author: | YANG CHIYUN |
---|---|
Other Authors: | BIOLOGICAL SCIENCES |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2018
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/138884 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Natural killer cell engineering for cellular therapy of cancer
by: Shook, D.R., et al.
Published: (2016) -
IMPROVING THE EFFICACY OF CHIMERIC ANTIGEN RECEPTOR-T CELLS FOR CANCER THERAPY
by: NATASHA VINANICA
Published: (2020) -
The Roles of CD38 and CD157 in the Solid Tumor Microenvironment and Cancer Immunotherapy
by: Wo, Y.J., et al.
Published: (2021) -
Vγ9Vδ2 T cells expressing a BCMA-Specific chimeric antigen receptor inhibit multiple myeloma xenograft growth
by: Zhang, X, et al.
Published: (2022) -
EVALUATION OF NOVEL ANTIBODIES FOR CHIMERIC ANTIGEN RECEPTOR T CELL APPLICATIONS
by: LEONARD WEN YAN LEONG
Published: (2021)